Literature DB >> 2944739

The rat testicular A1 adenosine receptor-adenylate cyclase system.

G L Stiles, G Pierson, S Sunay, W J Parsons.   

Abstract

When adenosine interacts with membrane-bound A1 receptors, it is capable of inhibiting the enzyme adenylate cyclase in brain and fat tissue. In this paper we characterize the A1 adenosine receptor-adenylate cyclase system of the rat testes. The agonist radioligand (-)-N-[3-[125I]iodo-4-hydroxyphenyl-(isopropyl)adenosine binds with high affinity (Kd, congruent to 1 nM) in a saturable manner (maximum binding, congruent to 600 fmol/mg protein). The A1 adenosine receptor binding displays the appropriate pharmacology, stereospecificity, and sensitivity to guanine nucleotides. The testicular A1 receptor is also coupled in an inhibitory manner to the enzyme adenylate cyclase, as demonstrated by the ability of N6-R-phenyl-2-propyladenosine to inhibit isoproterenol- and forskolin-stimulated cAMP accumulation. The testicular A1 receptor can be solubilized in high yield and in an active form with the detergent digitonin. The solubilized receptor retains all of the pharmacological properties of the membrane-bound receptor. Although there are many similarities among the A1 receptor from testes, brain, and fat tissue, the testicular A1 receptor displays a larger apparent mol wt. By photoaffinity labeling, the A1 adenosine receptor-binding subunit of fat and brain are 38,000 mol wt proteins, while the testicular A1 receptor binding subunit is a 42,000 mol wt protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944739     DOI: 10.1210/endo-119-4-1845

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Extracellular purines from cells of seminiferous tubules.

Authors:  Daniel Pens Gelain; Luiz Fernando de Souza; Elena Aida Bernard
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 2.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 3.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

Review 4.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

5.  Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors.

Authors:  M Ströher; C Nanoff; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.